ANUHPHR / NSE / Biotechnology & Drugs
Anuh Pharma
1Y Price Trend
Key Information
Recommendations
Target High115
Target Low66.72
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk35.94
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Anuh Pharma Ltd Technical Analysis: Momentum Shifts Signal Bearish Outlook Markets Mojo
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Anuh Pharma Ltd Valuation Shifts: From Attractive to Fair Amid Sector Comparisons Markets Mojo
Anuh Pharma Ltd is Rated Sell by MarketsMOJO Markets Mojo
ANUHPHR: FY26 revenue rose 15.66% to ₹776 Cr, driven by exports and regulatory market expansion TradingView
Anuh Pharma FY26 Revenue Jumps 16.65% to ₹771.66 Cr, PAT Declines Whalesbook
Anuh Pharma FY26 revenue rises 16.65% to ₹771.66 crore scanx.trade
Anuh Pharma promoters hold 7.19 crore shares in FY26 scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026

